APO Research
Talk to an analyst

APO RESEARCH · REPORT

Infrapopliteal Artery Stent

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Infrapopliteal Artery Stent Market Outlook and Growth Opportunities 2026

27 December 2025209 pages

Choose your research edition.

Industry ResearchInfrapopliteal Artery Stent Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Infrapopliteal Artery Stent Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Infrapopliteal Artery Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Infrapopliteal Artery Stent Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Infrapopliteal Artery Stent Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Infrapopliteal Artery Stent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Infrapopliteal Artery Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Infrapopliteal Artery Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Infrapopliteal Artery Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Infrapopliteal Artery Stent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Infrapopliteal Artery Stent market include OrbusNeich Medical Group, Abbott, Shanghai Microport Endovascular Medtech(Group), Acotec Scientific, Wei Qiang (Shanghai) Medical Technology, Medtronic, Leo Medical, Zylox-Tonbridge Medical Technology and Boston Scientific Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Infrapopliteal Artery Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Infrapopliteal Artery Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Infrapopliteal Artery Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Infrapopliteal Artery Stent market size, projected growth trends, production technologies, key applications, and end-use industries.

Infrapopliteal Artery Stent Segment by Company

OrbusNeich Medical Group

Abbott

Shanghai Microport Endovascular Medtech(Group)

Acotec Scientific

Wei Qiang (Shanghai) Medical Technology

Medtronic

Leo Medical

Zylox-Tonbridge Medical Technology

Boston Scientific Corporation

Zhejiang Barty Medical Technology

W.L. Gore & Associates

Terumo

Philips

Cordis Corporation

Cook Medical

Cardio Flow

Becton

BD

Infrapopliteal Artery Stent Segment by Type

Balloon Angioplasty

Stenting

Infrapopliteal Artery Stent Segment by Application

Iliac Artery

Femoral Artery

Other

Infrapopliteal Artery Stent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Infrapopliteal Artery Stent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Infrapopliteal Artery Stent market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Infrapopliteal Artery Stent significant trends, drivers, influence factors in global and regions.

6. To analyze Infrapopliteal Artery Stent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infrapopliteal Artery Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infrapopliteal Artery Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infrapopliteal Artery Stent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Infrapopliteal Artery Stent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Infrapopliteal Artery Stent industry.

Chapter 3: Detailed analysis of Infrapopliteal Artery Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Infrapopliteal Artery Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Infrapopliteal Artery Stent in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Infrapopliteal Artery Stent Industry Trends Table 2. Infrapopliteal Artery Stent Industry Drivers Table 3. Infrapopliteal Artery Stent Industry Opportunities and Challenges Table 4. Infrapopliteal Artery Stent Industry Restraints Table 5. Global Infrapopliteal Artery Stent Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Infrapopliteal Artery Stent Revenue Share by Company (2021-2026) Table 7. Global Infrapopliteal Artery Stent Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Infrapopliteal Artery Stent Sales Volume Share by Company (2021-2026) Table 9. Global Infrapopliteal Artery Stent Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Infrapopliteal Artery Stent Company Ranking, (2024-2026) & (USD Million) Table 11. Global Infrapopliteal Artery Stent Key Company Manufacturing Base & Headquarters Table 12. Global Infrapopliteal Artery Stent Company, Product Type & Application Table 13. Global Infrapopliteal Artery Stent Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Infrapopliteal Artery Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Balloon Angioplasty Table 18. Significant Companies of Stenting Table 19. Global Infrapopliteal Artery Stent Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Infrapopliteal Artery Stent Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Infrapopliteal Artery Stent Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Infrapopliteal Artery Stent Sales Volume Share by Type (2021-2026) Table 23. Global Infrapopliteal Artery Stent Sales Volume Share by Type (2027-2032) Table 24. Global Infrapopliteal Artery Stent Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Infrapopliteal Artery Stent Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Infrapopliteal Artery Stent Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Infrapopliteal Artery Stent Sales Value Share by Type (2021-2026) Table 28. Global Infrapopliteal Artery Stent Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Iliac Artery Table 30. Significant Companies of Femoral Artery Table 31. Significant Companies of Other Table 32. Global Infrapopliteal Artery Stent Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Infrapopliteal Artery Stent Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Infrapopliteal Artery Stent Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Infrapopliteal Artery Stent Sales Volume Share by Application (2021-2026) Table 36. Global Infrapopliteal Artery Stent Sales Volume Share by Application (2027-2032) Table 37. Global Infrapopliteal Artery Stent Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Infrapopliteal Artery Stent Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Infrapopliteal Artery Stent Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Infrapopliteal Artery Stent Sales Value Share by Application (2021-2026) Table 41. Global Infrapopliteal Artery Stent Sales Value Share by Application (2027-2032) Table 42. Global Infrapopliteal Artery Stent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Infrapopliteal Artery Stent Sales by Region (2021-2026) & (K Units) Table 44. Global Infrapopliteal Artery Stent Sales Market Share by Region (2021-2026) Table 45. Global Infrapopliteal Artery Stent Sales by Region (2027-2032) & (K Units) Table 46. Global Infrapopliteal Artery Stent Sales Market Share by Region (2027-2032) Table 47. Global Infrapopliteal Artery Stent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Infrapopliteal Artery Stent Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Infrapopliteal Artery Stent Sales Value Share by Region (2021-2026) Table 50. Global Infrapopliteal Artery Stent Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Infrapopliteal Artery Stent Sales Value Share by Region (2027-2032) Table 52. Global Infrapopliteal Artery Stent Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Infrapopliteal Artery Stent Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Infrapopliteal Artery Stent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Infrapopliteal Artery Stent Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Infrapopliteal Artery Stent Sales by Country (2021-2026) & (K Units) Table 57. Global Infrapopliteal Artery Stent Sales Market Share by Country (2021-2026) Table 58. Global Infrapopliteal Artery Stent Sales by Country (2027-2032) & (K Units) Table 59. Global Infrapopliteal Artery Stent Sales Market Share by Country (2027-2032) Table 60. Global Infrapopliteal Artery Stent Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Infrapopliteal Artery Stent Sales Value Market Share by Country (2021-2026) Table 62. Global Infrapopliteal Artery Stent Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Infrapopliteal Artery Stent Sales Value Market Share by Country (2027-2032) Table 64. OrbusNeich Medical Group Company Information Table 65. OrbusNeich Medical Group Business Overview Table 66. OrbusNeich Medical Group Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. OrbusNeich Medical Group Infrapopliteal Artery Stent Product Portfolio Table 68. OrbusNeich Medical Group Recent Development Table 69. Abbott Company Information Table 70. Abbott Business Overview Table 71. Abbott Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Abbott Infrapopliteal Artery Stent Product Portfolio Table 73. Abbott Recent Development Table 74. Shanghai Microport Endovascular Medtech(Group) Company Information Table 75. Shanghai Microport Endovascular Medtech(Group) Business Overview Table 76. Shanghai Microport Endovascular Medtech(Group) Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Shanghai Microport Endovascular Medtech(Group) Infrapopliteal Artery Stent Product Portfolio Table 78. Shanghai Microport Endovascular Medtech(Group) Recent Development Table 79. Acotec Scientific Company Information Table 80. Acotec Scientific Business Overview Table 81. Acotec Scientific Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Acotec Scientific Infrapopliteal Artery Stent Product Portfolio Table 83. Acotec Scientific Recent Development Table 84. Wei Qiang (Shanghai) Medical Technology Company Information Table 85. Wei Qiang (Shanghai) Medical Technology Business Overview Table 86. Wei Qiang (Shanghai) Medical Technology Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Wei Qiang (Shanghai) Medical Technology Infrapopliteal Artery Stent Product Portfolio Table 88. Wei Qiang (Shanghai) Medical Technology Recent Development Table 89. Medtronic Company Information Table 90. Medtronic Business Overview Table 91. Medtronic Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Medtronic Infrapopliteal Artery Stent Product Portfolio Table 93. Medtronic Recent Development Table 94. Leo Medical Company Information Table 95. Leo Medical Business Overview Table 96. Leo Medical Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Leo Medical Infrapopliteal Artery Stent Product Portfolio Table 98. Leo Medical Recent Development Table 99. Zylox-Tonbridge Medical Technology Company Information Table 100. Zylox-Tonbridge Medical Technology Business Overview Table 101. Zylox-Tonbridge Medical Technology Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Zylox-Tonbridge Medical Technology Infrapopliteal Artery Stent Product Portfolio Table 103. Zylox-Tonbridge Medical Technology Recent Development Table 104. Boston Scientific Corporation Company Information Table 105. Boston Scientific Corporation Business Overview Table 106. Boston Scientific Corporation Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Boston Scientific Corporation Infrapopliteal Artery Stent Product Portfolio Table 108. Boston Scientific Corporation Recent Development Table 109. Zhejiang Barty Medical Technology Company Information Table 110. Zhejiang Barty Medical Technology Business Overview Table 111. Zhejiang Barty Medical Technology Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Zhejiang Barty Medical Technology Infrapopliteal Artery Stent Product Portfolio Table 113. Zhejiang Barty Medical Technology Recent Development Table 114. W.L. Gore & Associates Company Information Table 115. W.L. Gore & Associates Business Overview Table 116. W.L. Gore & Associates Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. W.L. Gore & Associates Infrapopliteal Artery Stent Product Portfolio Table 118. W.L. Gore & Associates Recent Development Table 119. Terumo Company Information Table 120. Terumo Business Overview Table 121. Terumo Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Terumo Infrapopliteal Artery Stent Product Portfolio Table 123. Terumo Recent Development Table 124. Philips Company Information Table 125. Philips Business Overview Table 126. Philips Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Philips Infrapopliteal Artery Stent Product Portfolio Table 128. Philips Recent Development Table 129. Cordis Corporation Company Information Table 130. Cordis Corporation Business Overview Table 131. Cordis Corporation Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Cordis Corporation Infrapopliteal Artery Stent Product Portfolio Table 133. Cordis Corporation Recent Development Table 134. Cook Medical Company Information Table 135. Cook Medical Business Overview Table 136. Cook Medical Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Cook Medical Infrapopliteal Artery Stent Product Portfolio Table 138. Cook Medical Recent Development Table 139. Cardio Flow Company Information Table 140. Cardio Flow Business Overview Table 141. Cardio Flow Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Cardio Flow Infrapopliteal Artery Stent Product Portfolio Table 143. Cardio Flow Recent Development Table 144. Becton Company Information Table 145. Becton Business Overview Table 146. Becton Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Becton Infrapopliteal Artery Stent Product Portfolio Table 148. Becton Recent Development Table 149. BD Company Information Table 150. BD Business Overview Table 151. BD Infrapopliteal Artery Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. BD Infrapopliteal Artery Stent Product Portfolio Table 153. BD Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Infrapopliteal Artery Stent Distributors List Table 157. Infrapopliteal Artery Stent Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Infrapopliteal Artery Stent Product Image Figure 2. Global Infrapopliteal Artery Stent Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Infrapopliteal Artery Stent Sales Value (2021-2032) & (US$ Million) Figure 4. Global Infrapopliteal Artery Stent Sales (2021-2032) & (K Units) Figure 5. Global Infrapopliteal Artery Stent Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Infrapopliteal Artery Stent Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Balloon Angioplasty Image Figure 10. Stenting Image Figure 11. Global Infrapopliteal Artery Stent Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Infrapopliteal Artery Stent Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Infrapopliteal Artery Stent Sales Volume Share by Type (2021-2032) Figure 14. Global Infrapopliteal Artery Stent Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Infrapopliteal Artery Stent Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Infrapopliteal Artery Stent Sales Value Share by Type (2021-2032) Figure 17. Iliac Artery Image Figure 18. Femoral Artery Image Figure 19. Other Image Figure 20. Global Infrapopliteal Artery Stent Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Infrapopliteal Artery Stent Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Infrapopliteal Artery Stent Sales Volume Share by Application (2021-2032) Figure 23. Global Infrapopliteal Artery Stent Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Infrapopliteal Artery Stent Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Infrapopliteal Artery Stent Sales Value Share by Application (2021-2032) Figure 26. Global Infrapopliteal Artery Stent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Infrapopliteal Artery Stent Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Infrapopliteal Artery Stent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Infrapopliteal Artery Stent Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Infrapopliteal Artery Stent Sales Value (2021-2032) & (US$ Million) Figure 31. North America Infrapopliteal Artery Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Infrapopliteal Artery Stent Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Infrapopliteal Artery Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Infrapopliteal Artery Stent Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Infrapopliteal Artery Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Infrapopliteal Artery Stent Sales Value (2021-2032) & (US$ Million) Figure 37. South America Infrapopliteal Artery Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Infrapopliteal Artery Stent Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Infrapopliteal Artery Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Infrapopliteal Artery Stent Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Infrapopliteal Artery Stent Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Balloon Angioplasty
  • Stenting
Applications
  • Iliac Artery
  • Femoral Artery
  • Other
Companies covered
  • OrbusNeich Medical Group
  • Abbott
  • Shanghai Microport Endovascular Medtech(Group)
  • Acotec Scientific
  • Wei Qiang (Shanghai) Medical Technology
  • Medtronic
  • Leo Medical
  • Zylox-Tonbridge Medical Technology
  • Boston Scientific Corporation
  • Zhejiang Barty Medical Technology
  • W.L. Gore & Associates
  • Terumo
  • Philips
  • Cordis Corporation
  • Cook Medical
  • Cardio Flow
  • Becton
  • BD

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Infrapopliteal Artery Stent Sales Value (2021-2032)
  4. 1.2.2 Global Infrapopliteal Artery Stent Sales Volume (2021-2032)
  5. 1.2.3 Global Infrapopliteal Artery Stent Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Infrapopliteal Artery Stent Market Dynamics
  1. 2.1 Infrapopliteal Artery Stent Industry Trends
  2. 2.2 Infrapopliteal Artery Stent Industry Drivers
  3. 2.3 Infrapopliteal Artery Stent Industry Opportunities and Challenges
  4. 2.4 Infrapopliteal Artery Stent Industry Restraints
3 Infrapopliteal Artery Stent Market by Company
  1. 3.1 Global Infrapopliteal Artery Stent Company Revenue Ranking in 2025
  2. 3.2 Global Infrapopliteal Artery Stent Revenue by Company (2021-2026)
  3. 3.3 Global Infrapopliteal Artery Stent Sales Volume by Company (2021-2026)
  4. 3.4 Global Infrapopliteal Artery Stent Average Price by Company (2021-2026)
  5. 3.5 Global Infrapopliteal Artery Stent Company Ranking (2024-2026)
  6. 3.6 Global Infrapopliteal Artery Stent Company Manufacturing Base and Headquarters
  7. 3.7 Global Infrapopliteal Artery Stent Company Product Type and Application
  8. 3.8 Global Infrapopliteal Artery Stent Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Infrapopliteal Artery Stent Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Infrapopliteal Artery Stent Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Infrapopliteal Artery Stent Market by Type
  1. 4.1 Infrapopliteal Artery Stent Type Introduction
  2. 4.1.1 Balloon Angioplasty
  3. 4.1.2 Stenting
  4. 4.2 Global Infrapopliteal Artery Stent Sales Volume by Type
  5. 4.2.1 Global Infrapopliteal Artery Stent Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Infrapopliteal Artery Stent Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Infrapopliteal Artery Stent Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Infrapopliteal Artery Stent Sales Value by Type
  9. 4.3.1 Global Infrapopliteal Artery Stent Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Infrapopliteal Artery Stent Sales Value by Type (2021-2032)
  11. 4.3.3 Global Infrapopliteal Artery Stent Sales Value Share by Type (2021-2032)
5 Infrapopliteal Artery Stent Market by Application
  1. 5.1 Infrapopliteal Artery Stent Application Introduction
  2. 5.1.1 Iliac Artery
  3. 5.1.2 Femoral Artery
  4. 5.1.3 Other
  5. 5.2 Global Infrapopliteal Artery Stent Sales Volume by Application
  6. 5.2.1 Global Infrapopliteal Artery Stent Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Infrapopliteal Artery Stent Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Infrapopliteal Artery Stent Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Infrapopliteal Artery Stent Sales Value by Application
  10. 5.3.1 Global Infrapopliteal Artery Stent Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Infrapopliteal Artery Stent Sales Value by Application (2021-2032)
  12. 5.3.3 Global Infrapopliteal Artery Stent Sales Value Share by Application (2021-2032)
6 Infrapopliteal Artery Stent Regional Sales and Value Analysis
  1. 6.1 Global Infrapopliteal Artery Stent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Infrapopliteal Artery Stent Sales by Region (2021-2032)
  3. 6.2.1 Global Infrapopliteal Artery Stent Sales by Region: 2021-2026
  4. 6.2.2 Global Infrapopliteal Artery Stent Sales by Region (2027-2032)
  5. 6.3 Global Infrapopliteal Artery Stent Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Infrapopliteal Artery Stent Sales Value by Region (2021-2032)
  7. 6.4.1 Global Infrapopliteal Artery Stent Sales Value by Region: 2021-2026
  8. 6.4.2 Global Infrapopliteal Artery Stent Sales Value by Region (2027-2032)
  9. 6.5 Global Infrapopliteal Artery Stent Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Infrapopliteal Artery Stent Sales Value (2021-2032)
  12. 6.6.2 North America Infrapopliteal Artery Stent Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Infrapopliteal Artery Stent Sales Value (2021-2032)
  15. 6.7.2 Europe Infrapopliteal Artery Stent Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Infrapopliteal Artery Stent Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Infrapopliteal Artery Stent Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Infrapopliteal Artery Stent Sales Value (2021-2032)
  21. 6.9.2 South America Infrapopliteal Artery Stent Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Infrapopliteal Artery Stent Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Infrapopliteal Artery Stent Sales Value Share by Country, 2025 VS 2032
7 Infrapopliteal Artery Stent Country-level Sales and Value Analysis
  1. 7.1 Global Infrapopliteal Artery Stent Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Infrapopliteal Artery Stent Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Infrapopliteal Artery Stent Sales by Country (2021-2032)
  4. 7.3.1 Global Infrapopliteal Artery Stent Sales by Country (2021-2026)
  5. 7.3.2 Global Infrapopliteal Artery Stent Sales by Country (2027-2032)
  6. 7.4 Global Infrapopliteal Artery Stent Sales Value by Country (2021-2032)
  7. 7.4.1 Global Infrapopliteal Artery Stent Sales Value by Country (2021-2026)
  8. 7.4.2 Global Infrapopliteal Artery Stent Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Infrapopliteal Artery Stent Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Infrapopliteal Artery Stent Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Infrapopliteal Artery Stent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 OrbusNeich Medical Group
  2. 8.1.1 OrbusNeich Medical Group Company Information
  3. 8.1.2 OrbusNeich Medical Group Business Overview
  4. 8.1.3 OrbusNeich Medical Group Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 OrbusNeich Medical Group Infrapopliteal Artery Stent Product Portfolio
  6. 8.1.5 OrbusNeich Medical Group Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Infrapopliteal Artery Stent Product Portfolio
  12. 8.2.5 Abbott Recent Developments
  13. 8.3 Shanghai Microport Endovascular Medtech(Group)
  14. 8.3.1 Shanghai Microport Endovascular Medtech(Group) Company Information
  15. 8.3.2 Shanghai Microport Endovascular Medtech(Group) Business Overview
  16. 8.3.3 Shanghai Microport Endovascular Medtech(Group) Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Microport Endovascular Medtech(Group) Infrapopliteal Artery Stent Product Portfolio
  18. 8.3.5 Shanghai Microport Endovascular Medtech(Group) Recent Developments
  19. 8.4 Acotec Scientific
  20. 8.4.1 Acotec Scientific Company Information
  21. 8.4.2 Acotec Scientific Business Overview
  22. 8.4.3 Acotec Scientific Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Acotec Scientific Infrapopliteal Artery Stent Product Portfolio
  24. 8.4.5 Acotec Scientific Recent Developments
  25. 8.5 Wei Qiang (Shanghai) Medical Technology
  26. 8.5.1 Wei Qiang (Shanghai) Medical Technology Company Information
  27. 8.5.2 Wei Qiang (Shanghai) Medical Technology Business Overview
  28. 8.5.3 Wei Qiang (Shanghai) Medical Technology Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Wei Qiang (Shanghai) Medical Technology Infrapopliteal Artery Stent Product Portfolio
  30. 8.5.5 Wei Qiang (Shanghai) Medical Technology Recent Developments
  31. 8.6 Medtronic
  32. 8.6.1 Medtronic Company Information
  33. 8.6.2 Medtronic Business Overview
  34. 8.6.3 Medtronic Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Medtronic Infrapopliteal Artery Stent Product Portfolio
  36. 8.6.5 Medtronic Recent Developments
  37. 8.7 Leo Medical
  38. 8.7.1 Leo Medical Company Information
  39. 8.7.2 Leo Medical Business Overview
  40. 8.7.3 Leo Medical Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Leo Medical Infrapopliteal Artery Stent Product Portfolio
  42. 8.7.5 Leo Medical Recent Developments
  43. 8.8 Zylox-Tonbridge Medical Technology
  44. 8.8.1 Zylox-Tonbridge Medical Technology Company Information
  45. 8.8.2 Zylox-Tonbridge Medical Technology Business Overview
  46. 8.8.3 Zylox-Tonbridge Medical Technology Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Zylox-Tonbridge Medical Technology Infrapopliteal Artery Stent Product Portfolio
  48. 8.8.5 Zylox-Tonbridge Medical Technology Recent Developments
  49. 8.9 Boston Scientific Corporation
  50. 8.9.1 Boston Scientific Corporation Company Information
  51. 8.9.2 Boston Scientific Corporation Business Overview
  52. 8.9.3 Boston Scientific Corporation Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Boston Scientific Corporation Infrapopliteal Artery Stent Product Portfolio
  54. 8.9.5 Boston Scientific Corporation Recent Developments
  55. 8.10 Zhejiang Barty Medical Technology
  56. 8.10.1 Zhejiang Barty Medical Technology Company Information
  57. 8.10.2 Zhejiang Barty Medical Technology Business Overview
  58. 8.10.3 Zhejiang Barty Medical Technology Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Zhejiang Barty Medical Technology Infrapopliteal Artery Stent Product Portfolio
  60. 8.10.5 Zhejiang Barty Medical Technology Recent Developments
  61. 8.11 W.L. Gore & Associates
  62. 8.11.1 W.L. Gore & Associates Company Information
  63. 8.11.2 W.L. Gore & Associates Business Overview
  64. 8.11.3 W.L. Gore & Associates Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 W.L. Gore & Associates Infrapopliteal Artery Stent Product Portfolio
  66. 8.11.5 W.L. Gore & Associates Recent Developments
  67. 8.12 Terumo
  68. 8.12.1 Terumo Company Information
  69. 8.12.2 Terumo Business Overview
  70. 8.12.3 Terumo Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Terumo Infrapopliteal Artery Stent Product Portfolio
  72. 8.12.5 Terumo Recent Developments
  73. 8.13 Philips
  74. 8.13.1 Philips Company Information
  75. 8.13.2 Philips Business Overview
  76. 8.13.3 Philips Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Philips Infrapopliteal Artery Stent Product Portfolio
  78. 8.13.5 Philips Recent Developments
  79. 8.14 Cordis Corporation
  80. 8.14.1 Cordis Corporation Company Information
  81. 8.14.2 Cordis Corporation Business Overview
  82. 8.14.3 Cordis Corporation Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Cordis Corporation Infrapopliteal Artery Stent Product Portfolio
  84. 8.14.5 Cordis Corporation Recent Developments
  85. 8.15 Cook Medical
  86. 8.15.1 Cook Medical Company Information
  87. 8.15.2 Cook Medical Business Overview
  88. 8.15.3 Cook Medical Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Cook Medical Infrapopliteal Artery Stent Product Portfolio
  90. 8.15.5 Cook Medical Recent Developments
  91. 8.16 Cardio Flow
  92. 8.16.1 Cardio Flow Company Information
  93. 8.16.2 Cardio Flow Business Overview
  94. 8.16.3 Cardio Flow Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Cardio Flow Infrapopliteal Artery Stent Product Portfolio
  96. 8.16.5 Cardio Flow Recent Developments
  97. 8.17 Becton
  98. 8.17.1 Becton Company Information
  99. 8.17.2 Becton Business Overview
  100. 8.17.3 Becton Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Becton Infrapopliteal Artery Stent Product Portfolio
  102. 8.17.5 Becton Recent Developments
  103. 8.18 BD
  104. 8.18.1 BD Company Information
  105. 8.18.2 BD Business Overview
  106. 8.18.3 BD Infrapopliteal Artery Stent Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 BD Infrapopliteal Artery Stent Product Portfolio
  108. 8.18.5 BD Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Infrapopliteal Artery Stent Value Chain Analysis
  2. 9.1.1 Infrapopliteal Artery Stent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Infrapopliteal Artery Stent Sales Mode & Process
  6. 9.2 Infrapopliteal Artery Stent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Infrapopliteal Artery Stent Distributors
  9. 9.2.3 Infrapopliteal Artery Stent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst